Performance analysis of Prime Medicine (PRME)
Annual Return
Over the past 3 years, PRME has had an average annual return of -41.65%, underperforming the benchmark SPY, which returned +22.77% annual.
Since Oct 20, 2022, PRME has had an average annual return of -35.13%, underperforming the benchmark SPY, which returned +24.01% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -7.53% | +18.84% | -67.04% | -52.32% | +20.88% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +9.79% | +21.26% | -24.68% | +1.86% | +0.17% | -9.61% | -7.53% | ||||||
| 2025 | -4.11% | -9.99% | -21.04% | -13.05% | -31.79% | +109.24% | +51.40% | -13.36% | +70.97% | -10.82% | -22.68% | -9.13% | +18.84% |
| 2024 | -28.33% | +35.92% | -18.90% | -29.71% | +31.71% | -20.68% | +9.15% | -23.70% | -9.59% | +0.24% | -15.17% | -11.26% | -67.04% |
| 2023 | -5.38% | -6.54% | -25.14% | +11.95% | -0.37% | +6.79% | +2.86% | -12.15% | -27.94% | -31.96% | +11.84% | +22.04% | -52.32% |
| 2022 | +22.45% | -8.66% | +8.08% | +20.88% |
Drawdown analysis of Prime Medicine (PRME)
The maximum drawdown for the PRME was -94.56%, occurring on Apr 8, 2025. This drawdown has not yet recovered.
The current PRME drawdown is -84.80%.
Since Oct 20, 2022 PRME has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -94.56% | Nov 1, 2022 | 609 | Apr 8, 2025 | Ongoing | Ongoing | Ongoing |
| -3.56% | Oct 21, 2022 | 1 | Oct 24, 2022 | 1 | Oct 25, 2022 | 2 |